{"id":931,"date":"2015-11-05T00:00:00","date_gmt":"2015-11-04T23:00:00","guid":{"rendered":"http:\/\/semmelweis.hu\/symposium\/program\/"},"modified":"2015-11-05T14:21:06","modified_gmt":"2015-11-05T13:21:06","slug":"program","status":"publish","type":"page","link":"https:\/\/semmelweis.hu\/symposium\/szimpozium-archiv\/symposium2014\/program\/","title":{"rendered":"Program"},"content":{"rendered":"\n

Download – Pdf<\/a><\/p>\n

\n

November<\/strong> <\/strong>6<\/strong> <\/strong>(Thursday) <\/strong><\/h1>\n

Opening<\/strong><\/h2>\n

\u00c1goston Sz\u00e9l, Rector of Semmelweis University
Laszl\u00f3 Hunyady, Dean of Medical School
Gy\u00f6rgy Losonczy, Conference Chair<\/p>\n

<\/p>\n

8:30 \tOpening address<\/p>\n

\n

Agoston<\/em> <\/em>Szel,<\/em> <\/em>Rector<\/em> <\/em>of<\/em> <\/em>Semmefvveis<\/em> <\/em>University<\/em><\/p>\n

<\/p>\n<\/blockquote>\n

\n

\tI.<\/strong> <\/strong>Update<\/strong> <\/strong>on<\/strong> <\/strong>bronchial <\/strong> <\/strong>asthma<\/strong> <\/strong>and<\/strong> <\/strong>chronic<\/strong> <\/strong>obstructive<\/strong> <\/strong>pulmonary <\/strong>disease<\/strong> <\/strong>(COPD)<\/strong><\/h3>\n

Chair:<\/em> <\/em>lldik\u00f3<\/em> <\/em>Horvath<\/em><\/p>\n<\/blockquote>\n

9:00 Peter<\/em> <\/em>J.<\/em> <\/em>Bames,<\/em> <\/em>Imperial<\/em> <\/em>College,<\/em> <\/em>London,<\/em> <\/em>UK<\/em><\/p>\n

\n

New targets and treatments for COPD<\/p>\n<\/blockquote>\n

9:25 lldik\u00f3<\/em> <\/em>Horvath,<\/em> <\/em>Semmefvveis<\/em> <\/em>University<\/em> <\/em>and<\/em> <\/em>N<\/em>a<\/em>tio<\/em>n<\/em>a<\/em>l<\/em> <\/em>Koranyi<\/em> <\/em>Institute,<\/em> <\/em>Budapest, <\/em>Hun<\/em>g<\/em>ary<\/em><\/p>\n

\n

Big data in asthma phenotyping<\/p>\n<\/blockquote>\n

9:45 Andr\u00e1s Bikov<\/em><\/em><\/p>\n

\n

Innovative approaches in exhaled biomarker measurements<\/p>\n<\/blockquote>\n

10:10 Balazs<\/em> <\/em>Antus,<\/em> <\/em>N<\/em>a<\/em>tio<\/em>n<\/em>a<\/em>l <\/em> <\/em>Koranyi<\/em> <\/em>Institute,<\/em> <\/em>Budapest,<\/em> <\/em>Hungary<\/em><\/p>\n

\n

Airway biomarkers in COPD<\/p>\n<\/blockquote>\n

10:30 \tDiscussion<\/p>\n

10:40 \tBreak<\/strong><\/p>\n

<\/p>\n

\n

II.<\/strong> <\/strong>New<\/strong> <\/strong>therapeutic<\/strong> <\/strong>concepts<\/strong> <\/strong>in<\/strong> <\/strong>obstructive<\/strong> <\/strong>lung<\/strong> <\/strong>diseases<\/strong><\/h3>\n

Chair:<\/em> <\/em>Gabor<\/em> <\/em>Hor<\/em>v<\/em>a<\/em>t<\/em>h<\/em><\/p>\n<\/blockquote>\n

11:00 Adam<\/em> <\/em>Wanner,<\/em> <\/em>University<\/em> <\/em>of<\/em> <\/em>Miami,<\/em> <\/em>USA<\/em><\/p>\n

\n

Alpha-1 antitrypsin deficiency-related COPD<\/p>\n<\/blockquote>\n

11:25 Andreas<\/em> <\/em>Schmid,<\/em> <\/em>University<\/em> <\/em>of<\/em> <\/em>Miami,<\/em> <\/em>USA<\/em><\/p>\n

\n

Bronchiectasis: challenges in diagnosis and treatment<\/p>\n<\/blockquote>\n

11:50 Matthias<\/em> <\/em>S<\/em>a<\/em>lathe,<\/em> <\/em>University<\/em> <\/em>of<\/em> <\/em>Miami,<\/em> <\/em>USA<\/em><\/p>\n

\n

Novel approaches to correct cystic fibrosis related airway disease: relevance to COPD?<\/p>\n<\/blockquote>\n

12:15 Gabor<\/em> <\/em>Horvath,<\/em> <\/em>Semmefvveis<\/em> <\/em>University,<\/em> <\/em>Budapest,<\/em> <\/em>Hungary<\/em><\/p>\n

\n

Inhaled bronchodilators: mechanisms of drugs absorption in the airway <\/p>\n<\/blockquote>\n

12:35<\/strong> <\/strong> <\/strong>Discussion<\/strong><\/p>\n

12:45<\/strong> <\/strong> <\/strong>Lunch<\/strong><\/p>\n

<\/p>\n

\n

lll.<\/strong> <\/strong>Non-invasive<\/strong> <\/strong>ventilation<\/strong><\/h3>\n

Chair:<\/em> <\/em>Andras<\/em> <\/em>Lorx<\/em><\/p>\n<\/blockquote>\n

14:00 Wolfram<\/em> <\/em>Windisch,<\/em> <\/em>Merheim<\/em> <\/em>Lungenklinik,<\/em> <\/em>Cologne,<\/em> <\/em>Germany<\/em><\/p>\n

\n

Home non-invasive ventilation in COPD: what is the best approach?<\/p>\n<\/blockquote>\n

14:25 \tJozsef Lukacsovits,<\/em> <\/em>Semmelweis<\/em> <\/em>University,<\/em> <\/em>Budapest,<\/em> <\/em>Hungary<\/em><\/p>\n

\n

Physiological changes during low- and high-intensity non-invasive ventilation<\/p>\n<\/blockquote>\n

14:45 Piero<\/em> <\/em>Ceriana,<\/em> <\/em>Pavia,<\/em> <\/em>Italy<\/em><\/p>\n

\n

The difficult -to- wean patient: role of rehabilitation and non-invasive ventilation<\/p>\n<\/blockquote>\n

15:10 Andras<\/em> <\/em>Lorx,<\/em> <\/em>Semmelweis<\/em> <\/em>University,<\/em> <\/em>Budapest,<\/em> <\/em>Hungary<\/em><\/p>\n

\n

The grey zone: indications and limitations of non-invasive ventilation in acute settings<\/p>\n<\/blockquote>\n

15:30 Olli<\/em> <\/em>Polo,<\/em> <\/em>University<\/em> <\/em>of<\/em> <\/em>Turku,<\/em> <\/em>Finland<\/em><\/p>\n

\n

Sleep apnea and the autonomic nervous system<\/p>\n<\/blockquote>\n

15:55<\/strong> <\/strong> <\/strong>Discussion<\/strong> <\/p>\n

16:05<\/strong> <\/strong> <\/strong>Break<\/strong><\/p>\n

<\/p>\n

\n

IV.<\/strong> <\/strong>Pulmonary<\/strong> <\/strong>hypertension<\/strong><\/h3>\n

Chair:<\/em> <\/em>Kristof<\/em> <\/em>Karlocai<\/em><\/p>\n<\/blockquote>\n

16:20 Anna<\/em> <\/em>Csiszar, University<\/em> <\/em>of<\/em> <\/em>Oklahoma,<\/em> <\/em>Oklahoma<\/em> <\/em>City,<\/em> <\/em>USA<\/em><\/p>\n

\n

Ageing induced functional and phenotypic alterations in vascular cells<\/p>\n<\/blockquote>\n

16:45 Gabor<\/em> <\/em>Kovacs<\/em> <\/em>Jr.,<\/em> <\/em>Medical<\/em> <\/em>University<\/em> <\/em>of<\/em> <\/em>Graz,<\/em> <\/em>Austria<\/em><\/p>\n

\n

Right heart catheter at rest and exercise <\/p>\n<\/blockquote>\n

17:05 Horst<\/em> <\/em>Olschewski,<\/em> <\/em>Medical<\/em> <\/em>University<\/em> <\/em>of<\/em> <\/em>Graz,<\/em> <\/em>Austria<\/em><\/p>\n

\n

New therapies for pulmonary hypertension<\/p>\n<\/blockquote>\n

17:25 Kristof<\/em> <\/em>Karlocai,<\/em> <\/em>Semmelweis<\/em> <\/em>University,<\/em> <\/em>Budapest,<\/em> <\/em>Hungary<\/em><\/p>\n

\n

Pregnancy and pulmonary hypertension<\/p>\n<\/blockquote>\n

17:45<\/strong> <\/strong> <\/strong>Discussion<\/strong> <\/p>\n

<\/p>\n

November<\/strong> <\/strong>7<\/strong> <\/strong>(Friday)<\/strong><\/h1>\n

<\/p>\n

\n

V.<\/strong> <\/strong>Rehabilitation<\/strong> <\/strong>–<\/strong> <\/strong>Exercise<\/strong> <\/strong>physiology<\/strong><\/h3>\n

Chair:<\/em> <\/em>Attila<\/em> <\/em>Somfay<\/em><\/p>\n<\/blockquote>\n

8:30 Richard<\/em> <\/em>H.<\/em> <\/em>Casaburi,<\/em> <\/em>University<\/em> <\/em>of<\/em> <\/em>Califomia, <\/em>Los Angeles,<\/em> <\/em>USA<\/em><\/p>\n

\n

Pulmonary rehabilitation: a new focus on physical activity<\/p>\n<\/blockquote>\n

8:55 Attila<\/em> <\/em>Somfay,<\/em> <\/em>University<\/em> <\/em>of<\/em> <\/em>Szeged,<\/em> <\/em>Szeged,<\/em> <\/em>Hungary<\/em><\/p>\n

\n

Pharmacological and non-pharmacological interventions to reduce dynamic hyperinflation in patients with COPD<\/p>\n<\/blockquote>\n

9:15 Peter<\/em> <\/em>Apor;<\/em> <\/em>Semmelweis University,<\/em> <\/em>Budapest<\/em><\/p>\n

\n

Sarcopenia in pulmonology, cardiology and geriatrics<\/p>\n<\/blockquote>\n

9:35 Mikl\u00f3s<\/em> <\/em>T\u00f3th,<\/em> <\/em>Serrmelweis <\/em> <\/em>University,<\/em> <\/em>Budapest,<\/em> <\/em>Hungary<\/em><\/p>\n

\n

Exercise testing and mass-spectrometry<\/p>\n<\/blockquote>\n

9:55<\/strong> <\/strong> <\/strong>Discussion<\/strong><\/p>\n

10:05<\/strong> <\/strong> <\/strong>Break<\/strong><\/p>\n

<\/p>\n

\n

VI.<\/strong> <\/strong>Lung<\/strong> <\/strong>cancer<\/strong> <\/strong>1<\/strong><\/h3>\n

Chairs: Judit<\/em> <\/em>Moldvay<\/em><\/p>\n<\/blockquote>\n

10:25 Paolo<\/em> <\/em>Boffetta,<\/em> <\/em>Tisch<\/em> <\/em>Ca<\/em>n<\/em>c<\/em>er<\/em> <\/em>Institute,<\/em> <\/em>New<\/em> <\/em>York,<\/em> <\/em>USA<\/em><\/p>\n

\n

Screening of lung cancer<\/p>\n<\/blockquote>\n

11:50 Judit<\/em> <\/em>Moldvay,<\/em> <\/em>Semmelweis <\/em> <\/em>University,<\/em> <\/em>Budapest,<\/em> <\/em>Hungary<\/em><\/p>\n

\n

Tight junction proteins in lung cancer<\/p>\n<\/blockquote>\n

12:10 Helmuth<\/em> <\/em>Popper;<\/em> <\/em>University<\/em> <\/em>of<\/em> <\/em>Graz,<\/em> <\/em>Austria<\/em><\/p>\n

\n

Molecular pathology of non-small cell lung cancer<\/p>\n<\/blockquote>\n

12:35 <\/em>Mir Ali Reza Hoda, Medical University of Vienna, Austria<\/em><\/p>\n

\n

Recent developments and new therapeutic strategies in malignant pleural mesothelioma <\/p>\n<\/blockquote>\n

12.55<\/strong> <\/strong> <\/strong>Discussion<\/strong><\/p>\n

13:05<\/strong> <\/strong> <\/strong>Lunch<\/strong><\/p>\n

<\/p>\n

\n

VII.<\/strong> <\/strong>Asthma<\/strong> <\/strong>in<\/strong> <\/strong>pregnancy<\/strong><\/h3>\n

Chairs:<\/em> <\/em>Lilla<\/em> <\/em>Tamasi<\/em><\/p>\n<\/blockquote>\n

14:15 Christopher<\/em> <\/em>VII.<\/em> <\/em>G. Redman,<\/em> <\/em>John<\/em> <\/em>Redcliffe,<\/em> <\/em>Oxford,<\/em> <\/em>UK<\/em><\/p>\n

\n

Immunology of placentation<\/p>\n<\/blockquote>\n

14:45 Lilla<\/em> <\/em>Tamasi,<\/em> <\/em>Semmelweis<\/em> <\/em>University,<\/em> <\/em>Budapest,<\/em> <\/em>Hungary<\/em><\/p>\n

\n

Asthma in pregnancy: immune changes and monitoring<\/p>\n<\/blockquote>\n

15:00 Michael<\/em> <\/em>Schatz,<\/em> <\/em>Kaiser<\/em> <\/em>Permanente,<\/em> <\/em>San<\/em> <\/em>Diego,<\/em> <\/em>USA<\/em><\/p>\n

\n

Asthma in pregnancy: diagnosis and treatment<\/p>\n<\/blockquote>\n

15:25 \tJ\u00e1nos Rig<\/em>\u00f3<\/em>,<\/em> <\/em>Semmelweis<\/em> <\/em>University,<\/em> <\/em>Budapest, <\/em> <\/em>Hungary<\/em><\/p>\n

\n

Medical disorders and preeclampsia<\/p>\n<\/blockquote>\n

15:45<\/strong> <\/strong> <\/strong>Discussion<\/strong> <\/p>\n

15:55<\/strong> <\/strong> <\/strong>Break<\/strong><\/p>\n<\/p>\n

\n

VIII.<\/strong> <\/strong>Innate<\/strong> <\/strong>lymphoid<\/strong> <\/strong>cells<\/strong> <\/strong>and<\/strong> <\/strong>bronchial<\/strong> <\/strong>asthma<\/strong><\/h3>\n

Chair:<\/em> <\/em>Zsolt<\/em> <\/em>Koml\u00f3si<\/em><\/p>\n<\/blockquote>\n

16:15 Mubeccel<\/em> <\/em>Akdis,<\/em> <\/em>Swiss Institute<\/em> <\/em>of<\/em> <\/em>Allergy<\/em> <\/em>and<\/em> <\/em>Asthma<\/em> <\/em>Research,<\/em> <\/em>Davos, <\/em>Switzerland<\/em><\/p>\n

\n

Mechanisms of peripheral tolerance to allergens <\/p>\n<\/blockquote>\n

16:40 Zsolt<\/em> <\/em> <\/em>Koml\u00f3si,<\/em> <\/em>Semmelweis<\/em> <\/em>University,<\/em> <\/em>Budapest,<\/em> <\/em>Hungary<\/em><\/p>\n

\n

lmmunoregulatory role for ,type 3" innate lymphoid cells<\/p>\n<\/blockquote>\n

17:00 Burkhard<\/em> <\/em>Ludewig,<\/em> <\/em>St.<\/em> <\/em>Gallen,<\/em> <\/em>Switzerland<\/em><\/p>\n

\n

Stromal cells regulate lymphoid organ development and immune responsiveness<\/p>\n<\/blockquote>\n

17:25<\/strong> <\/strong> <\/strong>Discussion<\/strong><\/p>\n

17:35<\/strong> <\/strong> <\/strong>Break<\/strong><\/p>\n

<\/p>\n

IX.<\/strong> <\/strong>Lung<\/strong> <\/strong>cancer<\/strong> <\/strong>2<\/strong><\/h3>\n
\n

Chair:<\/em> <\/em>Gy\u00f6rgy<\/em> <\/em>Losonczy<\/em><\/p>\n<\/blockquote>\n

17:45 Jean-Paul<\/em> <\/em>Sculier;<\/em> <\/em>Free<\/em> <\/em>University<\/em> <\/em>of<\/em> <\/em>Brussels, Belgium<\/em><\/p>\n

\n

Targeted treatment of advanced stage non-small cell lung cancer<\/p>\n<\/blockquote>\n

18:10 Gy\u00f6rgy<\/em> <\/em>Losonczy,<\/em> <\/em>Semmelweis<\/em> <\/em>University,<\/em> <\/em>Budapest,<\/em> <\/em>Hungary<\/em><\/p>\n

\n

Risk and prevention of cisplatin nephrotoxicity<\/p>\n<\/blockquote>\n

18:25 Chris<\/em> <\/em>Baylis,<\/em> <\/em>University<\/em> <\/em>of<\/em> <\/em>Gainesville,<\/em> <\/em>Florida,<\/em> <\/em>USA<\/em><\/p>\n

\n

Physiology of toxic acute renal failure<\/p>\n<\/blockquote>\n

18:50<\/strong> <\/strong> <\/strong>Discussion<\/strong> <\/p>\n

20:00<\/strong> <\/strong> Gala<\/strong> <\/strong>Dinner<\/strong> <\/strong>(Marble <\/strong> <\/strong>Hall<\/strong> <\/strong>of<\/strong> <\/strong>the<\/strong> <\/strong>Museum <\/strong> <\/strong>of<\/strong> <\/strong>Military History,<\/strong> <\/strong>Buda<\/strong> <\/strong>Castle) <\/strong>November<\/strong> <\/strong>8,<\/strong> <\/strong>Saturday<\/strong><\/p>\n<\/p>\n

X.<\/strong> <\/strong>Pulmonary<\/strong> <\/strong>complications<\/strong> <\/strong>in<\/strong> <\/strong>solid<\/strong> <\/strong>organ<\/strong> <\/strong>transplantation<\/strong><\/h3>\n
\n

Chair:<\/em> <\/em>Veronika<\/em> <\/em>M\u00fcller<\/em><\/p>\n<\/blockquote>\n

8:30 Uwe<\/em> <\/em>Heemann,<\/em> <\/em>Technical<\/em> <\/em>University<\/em> <\/em>Munich<\/em><\/p>\n

\n

Optimizing immunosuppressive therapies to prevent pulmonary complications<\/p>\n<\/blockquote>\n

8:55 Veronika<\/em> <\/em>M\u00fcller;<\/em> <\/em>Semmelweis<\/em> <\/em>University,<\/em> <\/em>Budapest,<\/em> <\/em>Hungary <\/em>Pleuropulmonary changes in immunocompromized patients: infection or underlying disease?<\/p>\n

9:15 Gy\u00f6rgy<\/em> <\/em>Lang,<\/em> <\/em>Semmelweis<\/em> <\/em>University,<\/em> <\/em>Budapest<\/em> <\/em>and<\/em> <\/em>Medical<\/em> <\/em>University<\/em> <\/em>of<\/em> Vienna,<\/em> <\/em>Austria<\/em><\/p>\n

\n

Bridge therapies from end-stage lung disease to lung transplantation<\/p>\n<\/blockquote>\n

9:35 Nandor<\/em> <\/em>Marczin,<\/em> <\/em><\/em>Imperial College London, London, UK<\/em><\/p>\n

\n

Optimizing donor lungs and perioperative recipient care in lung transplantation<\/p>\n<\/blockquote>\n

10:00<\/strong> <\/strong> <\/strong>Discussion<\/strong><\/p>\n

10:10<\/strong> <\/strong> <\/strong>Break<\/strong><\/p>\n

10:25<\/strong> <\/strong> <\/strong>Semmelweis<\/strong> <\/strong>Budapest <\/strong> <\/strong>Award<\/strong> <\/strong>Ceremony<\/strong><\/p>\n

\n

Award Winner: Gy\u00f6rgy Klein, Nobel Laureate
Award is presented by \u00c1goston Sz\u00e9l, Rector of Semmelweis University<\/p>\n<\/blockquote>\n

11.00<\/strong> <\/strong> Closing<\/strong> <\/strong>remarks<\/strong><\/p>\n

\n

Gy\u00f6rgy<\/em> <\/em>Losonczy<\/em><\/p>\n<\/blockquote>\n

<\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Download – Pdf<\/a> November 6 (Thursday) Opening \u00c1goston Sz\u00e9l, Rector of Semmelweis University Laszl\u00f3 Hunyady, Dean of Medical School Gy\u00f6rgy Losonczy, Conference Chair 8:30 Opening address Agoston Szel, Rector of Semmefvveis University I. Update on bronchial asthma and chronic obstructive pulmonary disease (COPD) Chair: lldik\u00f3 Horvath 9:00 Peter J. Bames, Imperial College, London, UK New targets …<\/p>\n","protected":false},"author":101029,"featured_media":0,"parent":929,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-931","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/931","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/users\/101029"}],"replies":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/comments?post=931"}],"version-history":[{"count":1,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/931\/revisions"}],"predecessor-version":[{"id":947,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/931\/revisions\/947"}],"up":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/929"}],"wp:attachment":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/media?parent=931"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/categories?post=931"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/tags?post=931"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}